A Wake-up Call for Men: The 'Jolie Gene' and Its Impact on Cancer Risk
In 2013, the world was introduced to a gene that would forever change the way we view cancer prevention. Angelina Jolie's brave decision to undergo a preventative mastectomy shed light on the BRCA gene mutation, a silent threat lurking in the shadows for many. But here's where it gets controversial: this gene mutation isn't just a women's issue; it affects men too, and in a big way.
Jolie's personal story is a powerful reminder. Having lost her mother to ovarian cancer, she discovered she carried a mutation in the BRCA1 gene, a gene that normally helps repair damaged DNA and prevent tumors. For women, this mutation significantly increases the risk of breast and ovarian cancer, but for men, it's a different, often overlooked, battle.
Men with faulty BRCA1 genes are three times more likely to develop aggressive prostate cancer, and those with BRCA2 mutations are twice as likely. It's a stark reality that has prompted the National Screening Committee (NSC) to recommend a targeted screening strategy for this specific group of men.
According to Prostate Cancer UK, up to 30,000 men aged 45 to 61 could be eligible for testing every two years. However, the challenge lies in identifying these men, as most are unaware they carry the mutation. Typically, men only discover their BRCA status if a female relative, diagnosed with breast or ovarian cancer, undergoes DNA testing.
NHS genetic testing is currently limited, with a program focused on people with Jewish ancestry, who are at a higher risk of carrying BRCA gene faults. Those with a strong family history of cancer can request genetic testing from their GP, a simple process involving a saliva swab.
Professor Sir Mike Richards, chair of the NSC, acknowledges that their decision will lead to increased BRCA testing as men become more aware of the risk. He encourages women diagnosed with breast or ovarian cancer to "communicate to their male relatives" if they test positive for BRCA.
But this raises concerns about the potential burden on GPs and the fact that many men may still miss out on screening. If a person has a BRCA variant, there's a 50% chance their children will inherit it, highlighting the importance of expanded genetic testing.
Ben Lamb, a consultant surgeon, warns that the decision may drive a surge in testing from those who are educated, worried, and affluent, potentially overshadowing those men who are most in need. Professor Ros Eeles, a pioneer in BRCA gene research, questions the NSC's decision to offer testing only every two years, advocating for annual testing to prevent aggressive cancers from going unchecked.
The success of the NHS screening program for men with BRCA mutations relies on expanded genetic testing, according to Eeles. While the recommendation is a vital step forward, thousands of men could still be left out unless testing is made more accessible. The NHS needs to take action, offering BRCA testing to more men, especially those with a family history of BRCA carriers.
So, what does this mean for men? It's a call to action, a reminder to be proactive about their health, especially if they have a family history of cancer. The 'Jolie gene' may have brought attention to women's health, but its impact on men's health is just as significant and deserves equal attention.
And this is the part most people miss: cancer prevention is a shared responsibility. It's time to break the silence and ensure that men, just like women, have the knowledge and access to testing they need to take control of their health. The question remains: are we doing enough to ensure men are aware of their BRCA status and the potential risks it poses? It's a conversation we need to have, and one that could save lives.
